Drug therapy reviews: antirheumatic agents.
The pathophysiology, symptoms and drug treatment of rheumatic disease are reviewed. Antirheumatic drugs reviewed are salicylates (including aspirin, sodium salicylate, choline salicylate, choline magnesium salicylate, salsalate), phenylpropionic acid derivatives (fenoprofen, ibuprofen, naproxen), indole derivatives (sulindac, tolmetin and indomethacin), pyrazolone derivatives (phenylbutazone, oxyphenbutazone), gold compounds, penicillamine, antimalarials mefenamic acid, corticosteroids and immunosuppressives. Simple analgesic therapy (acetaminophen, aspirin, propoxyphene) is used in the early stage of the disease. As the disease progresses, aspirin remains the drug of choice for antiinflammatory activity but the phenylpropionic acid or indole derivatives may be preferred in patients unable to tolerate salicylates. If such nonsteroidal antiinflammatory agents are not effective, parenteral therapy with gold compounds or oral penicillamine usually is indicated. Indomethacin or phenylbutazone, then antimalarials, are resorted to next. Corticosteroids or immunosuppressives are reserved for patients who are unsuccessfully controlled or who have major side effects with the other drugs. Mefenamic acid occupies a very secondary place in rheumatoid arthritis treatment.
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000962:Antimalarials / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006046:Gold / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007213:Indomethacin / Q000627:therapeutic use; D008528:Mefenamic Acid / Q000627:therapeutic use; D010396:Penicillamine / Q000627:therapeutic use; D010653:Phenylbutazone / Q000627:therapeutic use; D010666:Phenylpropionates / Q000627:therapeutic use; D012216:Rheumatic Diseases / Q000188:drug therapy* / Q000503:physiopathology; D012459:Salicylates / Q000627:therapeutic use; D013467:Sulindac / Q000627:therapeutic use; D014046:Tolmetin / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D000962:Antimalarials; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D010666:Phenylpropionates; D012459:Salicylates; D013467:Sulindac; D008528:Mefenamic Acid; D006046:Gold; D014046:Tolmetin; D010653:Phenylbutazone; D010396:Penicillamine; D007213:Indomethacin